Our previous study has reported AIM2 downregulation in CRC cell tissues and lines, indicating its promise as a diagnostic and prognostic biomarker similar to serum carcinoembryonic antigen in CRC [6]. This evidence concerns the gene CEACAM5 and colorectal carcinoma.